Affinity Asset Advisors’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
967,620
+156,951
| +19% | +$1.79M | 1.51% | 21 |
|
|
2025
Q1 | $9.63M | Sell |
810,669
-129,414
| -14% | -$1.54M | 0.92% | 22 |
|
|
2024
Q4 | $17.7M | Buy |
940,083
+79,684
| +9% | +$1.5M | 2.37% | 14 |
|
|
2024
Q3 | $19.3M | Sell |
860,399
-51,601
| -6% | -$1.16M | 2.64% | 9 |
|
|
2024
Q2 | $19M | Buy |
912,000
+101,747
| +13% | +$2.12M | 2.19% | 8 |
|
|
2024
Q1 | $11.9M | Buy |
810,253
+120,141
| +17% | +$1.77M | 1.47% | 17 |
|
|
2023
Q4 | $7.12M | Buy |
690,112
+440,112
| +176% | +$4.54M | 1.3% | 22 |
|
|
2023
Q3 | $1.97M | Buy |
250,000
+150,000
| +150% | +$1.18M | 0.55% | 39 |
|
|
2023
Q2 | $999K | Sell |
100,000
-50,000
| -33% | -$500K | 0.35% | 45 |
|
|
2023
Q1 | $1.33M | Buy |
150,000
+70,000
| +88% | +$622K | 0.44% | 43 |
|
|
2022
Q4 | $878K | Buy |
+80,000
| New | +$878K | 0.34% | 43 |
|